• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贵金属有机金属配合物对 SARS-CoV-2 显示抗病毒活性。

Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2.

机构信息

Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA 24061, USA.

Department of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.

出版信息

Viruses. 2021 May 25;13(6):980. doi: 10.3390/v13060980.

DOI:10.3390/v13060980
PMID:34070524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8227008/
Abstract

SARS-CoV-2 emerged in 2019 as a devastating viral pathogen with no available preventative or treatment to control what led to the current global pandemic. The continued spread of the virus and increasing death toll necessitate the development of effective antiviral treatments to combat this virus. To this end, we evaluated a new class of organometallic complexes as potential antivirals. Our findings demonstrate that two pentamethylcyclopentadienyl (Cp*) rhodium piano stool complexes, CpRh(1,3-dicyclohexylimidazol-2-ylidene)Cl (complex 2) and CpRh(dipivaloylmethanato)Cl (complex 4), have direct virucidal activity against SARS-CoV-2. Subsequent in vitro testing suggests that complex 4 is the more stable and effective complex and demonstrates that both 2 and 4 have low toxicity in Vero E6 and Calu-3 cells. The results presented here highlight the potential application of organometallic complexes as antivirals and support further investigation into their activity.

摘要

SARS-CoV-2 于 2019 年出现,是一种具有破坏性的病毒病原体,目前尚无预防或治疗方法来控制这种病毒,导致了当前的全球大流行。病毒的持续传播和死亡人数的不断增加,需要开发有效的抗病毒治疗方法来对抗这种病毒。为此,我们评估了一类新的有机金属配合物作为潜在的抗病毒药物。我们的研究结果表明,两种五甲基环戊二烯基(Cp*)铑钢琴凳配合物,CpRh(1,3-二环己基咪唑-2-亚基)Cl(配合物 2)和 CpRh(二(戊酰基)甲叉)Cl(配合物 4),对 SARS-CoV-2 具有直接的病毒杀灭活性。随后的体外测试表明,配合物 4 是更稳定和有效的配合物,并且证明 2 和 4 在 Vero E6 和 Calu-3 细胞中均具有低毒性。这里提出的结果强调了有机金属配合物作为抗病毒药物的潜在应用,并支持进一步研究其活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/a6742df9d465/viruses-13-00980-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/8d7524f00654/viruses-13-00980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/123e31e9c5e2/viruses-13-00980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/fbb197778a47/viruses-13-00980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/c7b0f900c91f/viruses-13-00980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/d566b0e44310/viruses-13-00980-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/fa21676675fe/viruses-13-00980-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/a6742df9d465/viruses-13-00980-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/8d7524f00654/viruses-13-00980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/123e31e9c5e2/viruses-13-00980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/fbb197778a47/viruses-13-00980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/c7b0f900c91f/viruses-13-00980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/d566b0e44310/viruses-13-00980-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/fa21676675fe/viruses-13-00980-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c347/8227008/a6742df9d465/viruses-13-00980-g007.jpg

相似文献

1
Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2.贵金属有机金属配合物对 SARS-CoV-2 显示抗病毒活性。
Viruses. 2021 May 25;13(6):980. doi: 10.3390/v13060980.
2
Gallium maltolate has antiviral activity against SARS-CoV-2 and is a potential treatment for COVID-19.麦芽酚镓对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)具有抗病毒活性,是一种治疗新型冠状病毒肺炎(COVID-19)的潜在药物。
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620983780. doi: 10.1177/2040206620983780.
3
Antiviral Activity of the Propylamylatin Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions.采用直接注射和气体检测法在病毒悬浮液中评估丙戊酰拉亭配方对新型冠状病毒 SARS-CoV-2 的抗病毒活性
Viruses. 2021 Mar 5;13(3):415. doi: 10.3390/v13030415.
4
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.阿昔莫司钠对 SARS-CoV-2 的体外抗病毒和病毒杀灭活性。
Antiviral Res. 2021 Jul;191:105089. doi: 10.1016/j.antiviral.2021.105089. Epub 2021 May 16.
5
The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.罗卡胍 CR-31-B(-)在体外和离体条件下以非细胞毒性、低纳摩尔浓度抑制 SARS-CoV-2 复制。
Antiviral Res. 2021 Feb;186:105012. doi: 10.1016/j.antiviral.2021.105012. Epub 2021 Jan 8.
6
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.用于高通量抗病毒筛选和测试的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)报告基因复制子的构建
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2025866118.
7
The CO Extract (Ze 339) Blocks SARS-CoV-2 Replication In Vitro.CO 提取物(Ze339)可阻断 SARS-CoV-2 在体外的复制。
Viruses. 2022 Jan 7;14(1):106. doi: 10.3390/v14010106.
8
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.肽偶联吗啉代寡聚体抑制 Vero 细胞培养中的 SARS-CoV-2。
J Antimicrob Chemother. 2021 Jan 19;76(2):413-417. doi: 10.1093/jac/dkaa460.
9
Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.血红素加氧酶-1 诱导剂血红素不能抑制 SARS-CoV-2 病毒感染。
Biomed Pharmacother. 2021 May;137:111384. doi: 10.1016/j.biopha.2021.111384. Epub 2021 Feb 13.
10
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.具有体外抗病毒活性和免疫调节作用的半胱胺有可能成为治疗 COVID-19 的重新定位药物候选物。
Cells. 2021 Dec 24;11(1):52. doi: 10.3390/cells11010052.

引用本文的文献

1
Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release .贝壳杉烯酸是一种有效的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA合成、病毒体组装和释放抑制剂。
Front Microbiol. 2025 May 9;16:1540934. doi: 10.3389/fmicb.2025.1540934. eCollection 2025.
2
Metal-Based Drug-DNA Interactions and Analytical Determination Methods.基于金属的药物-DNA 相互作用及其分析测定方法。
Molecules. 2024 Sep 13;29(18):4361. doi: 10.3390/molecules29184361.
3
Review on the Applications of Selected Metal-Based Complexes on Infectious Diseases.

本文引用的文献

1
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.尽管血清阳性率很高,巴西玛瑙斯仍出现新冠病毒的卷土重来。
Lancet. 2021 Feb 6;397(10273):452-455. doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.
2
Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan.使用心律失常风险管理计划降低接受羟氯喹和阿奇霉素治疗的COVID-19患者的心律失常风险。
Int J Cardiol Heart Vasc. 2020 Dec 11;32:100685. doi: 10.1016/j.ijcha.2020.100685. eCollection 2021 Feb.
3
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
金属基配合物在传染病中的应用综述。
Molecules. 2024 Jan 14;29(2):406. doi: 10.3390/molecules29020406.
4
Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections.钌(II)配合物作为对抗癌症和病毒感染的有前景的双活性药物。
Pharmaceuticals (Basel). 2023 Dec 15;16(12):1729. doi: 10.3390/ph16121729.
5
Silver N-heterocyclic carbene complexes are potent uncompetitive inhibitors of the papain-like protease with antiviral activity against SARS-CoV-2.银氮杂环卡宾配合物是木瓜蛋白酶样蛋白酶的有效非竞争性抑制剂,对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)具有抗病毒活性。
RSC Med Chem. 2023 May 16;14(7):1260-1271. doi: 10.1039/d3md00067b. eCollection 2023 Jul 20.
6
Half-Sandwich Type Platinum-Group Metal Complexes of -Glucosaminyl Azines: Synthesis and Antineoplastic and Antimicrobial Activities.半夹心型铂族金属配合物的 -氨基葡萄糖基氮嗪:合成及抗肿瘤和抗微生物活性。
Molecules. 2023 Mar 29;28(7):3058. doi: 10.3390/molecules28073058.
7
Metallo-antiviral aspirants: .金属抗病毒药物候选物: 。
Eur J Med Chem Rep. 2023 Aug;8:100104. doi: 10.1016/j.ejmcr.2023.100104. Epub 2023 Apr 4.
8
Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs.纳米技术在抗击 COVID-19 中的应用:从创新纳米材料到计算机辅助发现潜在的抗病毒植物衍生药物。
Biomolecules. 2022 Jul 30;12(8):1060. doi: 10.3390/biom12081060.
9
In silico study of potential antiviral activity of copper(II) complexes with non-steroidal anti-inflammatory drugs on various SARS-CoV-2 target proteins.计算机模拟研究非甾体抗炎药物与铜(II)配合物对多种 SARS-CoV-2 靶蛋白的潜在抗病毒活性。
J Inorg Biochem. 2022 Jun;231:111805. doi: 10.1016/j.jinorgbio.2022.111805. Epub 2022 Mar 18.
10
: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu, Ru, Ir Complexes.膦基铜、钌、铱配合物的合成、物理化学性质及生物学性质
Pharmaceuticals (Basel). 2022 Jan 29;15(2):169. doi: 10.3390/ph15020169.
通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.
4
Virology, transmission, and pathogenesis of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的病毒学、传播与发病机制
BMJ. 2020 Oct 23;371:m3862. doi: 10.1136/bmj.m3862.
5
Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics*.靶向冠状病毒蛋白的金金属药物:金诺芬和金有机金属对刺突-ACE2 相互作用和 PLpro 蛋白酶活性的抑制作用*。
Chemistry. 2020 Nov 26;26(66):15140-15144. doi: 10.1002/chem.202004112. Epub 2020 Oct 19.
6
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?抗冠状病毒药物:治疗新型冠状病毒肺炎(SARS-CoV-2)的候选药物?
Front Microbiol. 2020 Aug 13;11:1818. doi: 10.3389/fmicb.2020.01818. eCollection 2020.
7
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.一项在成人中开展的 COVID-19 RNA 疫苗 BNT162b1 的 I/II 期研究。
Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12.
8
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
9
A Surface Coating that Rapidly Inactivates SARS-CoV-2.一种能快速使 SARS-CoV-2 失活的表面涂层。
ACS Appl Mater Interfaces. 2020 Aug 5;12(31):34723-34727. doi: 10.1021/acsami.0c11425. Epub 2020 Jul 27.
10
Severe COVID-19: A Review of Recent Progress With a Look Toward the Future.严重的 COVID-19:近期进展回顾及未来展望。
Front Public Health. 2020 May 13;8:189. doi: 10.3389/fpubh.2020.00189. eCollection 2020.